Oncopeptides AB (publ)
ONPPF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $569 | $627 | $411 | $427 |
| - Cash | $107 | $179 | $250 | $383 |
| + Debt | $118 | $122 | $117 | $115 |
| Enterprise Value | $580 | $570 | $278 | $159 |
| Revenue | $13 | $10 | $9 | $8 |
| % Growth | 33.8% | 16.5% | 4.3% | – |
| Gross Profit | $13 | $9 | $8 | $7 |
| % Margin | 100.6% | 92.7% | 91.8% | 88.4% |
| EBITDA | -$60 | -$83 | -$61 | -$73 |
| % Margin | -451% | -840.6% | -720% | -898.2% |
| Net Income | -$61 | -$83 | -$60 | -$73 |
| % Margin | -457.3% | -841.5% | -708% | -898.1% |
| EPS Diluted | -0.28 | -0.39 | -0.39 | -0.48 |
| % Growth | 28.2% | 0% | 18.7% | – |
| Operating Cash Flow | – | -$71 | -$130 | $9 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$71 | -$130 | $9 |